Home / Resource Library / FIXED-DURATION PIRTOBRUTINIB PLUS VENETOCLAX-RITUXIMAB VERSUS VENETOCLAX-RITUXIMAB FOR PATIENTS WITH PREVIOUSLY TREATED CLL/SLL: A PHASE 3, RANDOMIZED TRIAL (BRUIN CLL-322)

FIXED-DURATION PIRTOBRUTINIB PLUS VENETOCLAX-RITUXIMAB VERSUS VENETOCLAX-RITUXIMAB FOR PATIENTS WITH PREVIOUSLY TREATED CLL/SLL: A PHASE 3, RANDOMIZED TRIAL (BRUIN CLL-322)

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

FIXED-DURATION PIRTOBRUTINIB PLUS VENETOCLAX-RITUXIMAB VERSUS VENETOCLAX-RITUXIMAB FOR PATIENTS WITH PREVIOUSLY TREATED CLL/SLL: A PHASE 3, RANDOMIZED TRIAL (BRUIN CLL-322)